Repurposed Drugs and Plant-Derived Natural Products as Potential Host-Directed Therapeutic Candidates for Tuberculosis
Biomolecules · 24.11.2024 · 14 (12) · 1497
DOI: 10.3390/biom14121497 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 24.11.2024. Verfasst von Rubhana Raqib und 1 weiteren Autor:innen. Beteiligte Einrichtung: Immunobiology, Nutrition and Toxicology Unit, Nutrition Research Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)…. Hauptthemen laut MEDLINE: Antitubercular Agents, Biological Products, Drug Repositioning, Extensively Drug-Resistant Tuberculosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Governments of Bangladesh and Canada.
Abstract (Originalsprache)
Tuberculosis (TB) is one of the leading causes of death due to infectious disease. It is a treatable disease; however, conventional treatment requires a lengthy treatment regimen with severe side effects, resulting in poor compliance among TB patients. Intermittent drug use, the non-compliance of patients, and prescription errors, among other factors, have led to the emergence of multidrug-resistant TB, while the mismanagement of multidrug-resistant TB (MDR-TB) has eventually led to the development of extensively drug-resistant tuberculosis (XDR-TB). Thus, there is an urgent need for new drug development, but due to the enormous expenses and time required (up to 20 years) for new drug research and development, new therapeutic approaches to TB are required. Host-directed therapies (HDT) could be a most attractive strategy, as they target the host defense processes instead of the microbe and thereby may prevent the alarming rise of MDR- and XDR-TB. This paper reviews the progress in HDT for the treatment of TB using repurposed drugs which have been investigated in clinical trials (completed or ongoing) and plant-derived natural products that are in clinical or preclinical trial stages. Additionally, this review describes the existing challenges to the development and future research directions in the implementation of HDT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunobiology, Nutrition and Toxicology Unit, Nutrition Research Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka 1212, Bangladesh.
ORCID-Profile: Rubhana Raqib, Protim Sarker
Förderung
- Governments of Bangladesh and Canada
Zitieren
APA
Raqib, R., & Sarker, P. (2024). Repurposed Drugs and Plant-Derived Natural Products as Potential Host-Directed Therapeutic Candidates for Tuberculosis. Biomolecules, 14(12), 1497. https://doi.org/10.3390/biom14121497
Vancouver
Raqib R, Sarker P. Repurposed Drugs and Plant-Derived Natural Products as Potential Host-Directed Therapeutic Candidates for Tuberculosis. Biomolecules. 2024;14(12):1497. doi:10.3390/biom14121497
BibTeX
@article{Raqib2024,
author = {Raqib, Rubhana and Sarker, Protim},
title = {Repurposed Drugs and Plant-Derived Natural Products as Potential Host-Directed Therapeutic Candidates for Tuberculosis},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {12},
pages = {1497},
doi = {10.3390/biom14121497}
}
EUVIMED